Global markets fell amidst concerns of a manufacturing slowdown in China. U.S. markets extended losses with the Dow plummeting 116 points to 16,080. Nasdaq dropped 35 points to 4183.
On the upside
BioDelivery Sciences (Nasdaq: BDSI) reported positive results from a Phase III clinical trial of its chronic pain treatment BEMA buprenorphine.
Microsoft (Nasdaq: MSFT) reported higher second quarter earnings and revenue that beat analyst expectations.
Juniper Networks (NYSE: JNPR) reported sharply higher fourth quarter earnings that surpassed analyst expectations as revenue climbed.
On the downside
Atossa Genetics (Nasdaq: ATOS) priced its public offering of 5.8 million units at the discounted price of $2.40 per unit.
Kansas City Southern (NYSE: KSU) reported higher fourth quarter earnings but the results fell short of analyst expectations.
First quarter earnings rose for International Game Technology (NYSE: IGT) but the results misses estimates.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 1 on the NYSE and by a margin of more than 4 to 1 on Nasdaq. The broader S&P 500 fell 13 points to 1814. Bitcoin lost $31.68 or 3.47% to $913.09.
